髂静脉血栓性疾病治疗

doi:10.16139/j.1007-9610.2024.06.01

摘要/Abstract

摘要：

目前，髂静脉血栓性疾病的治疗策略已从早期的单纯抗凝治疗、手术取栓和改善静脉回流等方法，逐步演变为包括药物溶栓、导管接触性溶栓及机械血栓清除在内的多种治疗手段。这些治疗手段趋向于微创，治疗效果和安全性均有所提升。随着治疗手段的多样化，静脉血栓栓塞症治疗理念亦不断更新，对治疗效果和安全性提出了更高标准。本文探讨了髂静脉血栓性疾病的治疗进展，旨在梳理各种临床治疗方式在髂静脉血栓性疾病治疗中的地位和作用，并为临床医师提供循证治疗建议。期待对诊断与治疗方案进一步规范化，并加强对预防的重视，以保障广大民众的血管健康。

关键词: 髂静脉血栓, 下肢深静脉血栓, 抗凝, 溶栓, 介入治疗

Abstract:

Currently, the treatment strategy for iliac venous thromboembolic disease has evolved from early approaches such as simple anticoagulation therapy, surgical thrombectomy, and venous return improvement to encompass multiple minimally invasive modalities including pharmacologic thrombolysis, catheter-directed thrombolysis (CDT), and mechanical thrombectomy. These advancements have demonstrated enhanced therapeutic efficacy and safety profiles. With the diversification of treatment modalities, the therapeutic concepts for venous thromboembolism (VTE) continue to be updated, establishing higher standards for treatment outcomes and safety. This article explored recent progress in the management of iliac venous thromboembolic disease, aiming to clarify the roles and efficacy of various treatment approaches in clinical practice while providing evidence-based treatment recommendation for clinicians. We anticipated further standardization of diagnostic and therapeutic protocols, along with increased emphasis on preventive measures, to safeguard vascular health in the general population.

Key words: Iliac vein thrombosis, Lower extremities deep venous thrombosis(LEDVT), Anticoagulation, Thrombolysis, Interventional therapy

中图分类号:

R543.6

谢新胜, 黄玉龙, 王利新. 髂静脉血栓性疾病治疗[J]. 外科理论与实践, 2024, 29(06): 463-471.

XIE Xinsheng, HUANG Yulong, WANG Lixin. Treatment of iliac vein thrombotic diseases[J]. Journal of Surgery Concepts & Practice, 2024, 29(06): 463-471.

参考文献 50

[1]	牛帅, 马百涛, 张锐, 等. 急性髂股静脉血栓治疗策略的研究进展[J]. 中华外科杂志, 2021, 59(9):796-800.
	NIU S, MA B T, ZHANG R, et al. Treatment strategies and research progress of acute ilio-femoral deep vein thrombosis[J]. Chin J Surg, 2021, 59(9):796-800.
[2]	祖庆佩, 朱吉海. 静脉血栓栓塞症治疗的新进展[J]. 临床医学进展, 2023, 13(6):10081-10087.
	ZU Q P, ZHU J H. New advances in the treatment of venous thromboembolism[J]. Adv Clin Med, 2023, 13(6):10081-10087.
[3]	张至, 刘旭峰, 谷雪芳, 等. 老年人血栓性疾病的防治--依据《中国血栓性疾病防治指南 (2018年)》的临床指导[J]. 中国临床保健杂志, 2019, 22(3):311-315.
	ZHANG Z, LIU X F, GU X F, et al. Prevention and treatment of senile thrombotic diseases[J]. Chin J Clin Healthc, 2019, 22(3):311-315.
[4]	KEARON C, AKL E A, ORNELAS J, et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report[J]. Chest, 2016, 149(2):315-352. doi: S0012-3692(15)00335-9 pmid: 26867832
[5]	中华医学会外科学分会血管外科学组. 深静脉血栓形成的诊断和治疗指南(第三版)[J]. 中华普通外科杂志, 2017, 32(9):807-812.
	Vascular Surgery Group, Chinese Society of Surgery, Chinese Medical Association. Guidelines for the diagnosis and treatment of deep vein thrombosis (Third Edition)[J]. Chin J Gen Surg, 2017, 32(9):807-812.
[6]	陈忠, 杨耀国. “静脉血栓栓塞症”的认知变迁和现代治疗理念[J]. 中华血管外科杂志, 2023, 08(2):159-166.
	CHEN Z, YANG Y G. Cognitive changes and modern treatment concepts of “venous thromboembolism”[J]. Chin J Vasc Surg, 2023, 8(2):159-166.
[7]	刘辉, 承文龙, 卢辉俊. 导管溶栓与系统溶栓治疗急性下肢深静脉血栓形成的Meta分析[J]. 中国血管外科杂志(电子版), 2016, 8(3):183-187.
	LIU H, CHENG W L, LU H J. Catheter-directed thrombolysis versus systemic thrombolysis for acute lower extremity deep venous thrombosis:a Meta-analysis[J]. Chin J Vasc Surg(Electronic Version), 2016, 8(3):183-187.
[8]	PLANER D, YANKO S, MATOK I, et al. Catheter-directed thrombolysis compared with systemic thrombolysis and anticoagulation in patients with intermediate- or high-risk pulmonary embolism: systematic review and network meta-analysis[J]. CMAJ, 2023, 195(24):E833-E843.
[9]	POPURI R K, VEDANTHAM S. The role of thrombolysis in the clinical management of deep vein thrombosis[J]. Arterioscler Thromb Vasc Biol, 2011, 31(3):479-484. doi: 10.1161/ATVBAHA.110.213413 pmid: 21325669
[10]	FLECK D, ALBADAWI H, SHAMOUN F, et al. Catheter-directed thrombolysis of deep vein thrombosis: literature review and practice considerations[J]. Cardiovasc Diagn Ther, 2017, 7(Suppl 3):s228-s237.
[11]	CHEN X, LUO Q, XU W, et al. Comparative study of two different access points, one tibial vein and the popliteal vein, for catheter-directed thrombolysis in the treatment of acute mixed lower extremity deep vein thrombosis[J]. Ann Vasc Surg, 2025, 110(Pt B):110-119.
[12]	ENDEN T, HAIG Y, KLØW N E, et al. Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial[J]. Lancet, 2012, 379(9810):31-38.
[13]	VEDANTHAM S, GOLDHABER S Z, KAHN S R, et al. Rationale and design of the ATTRACT Study: a multicenter randomized trial to evaluate pharmacomechanical catheter-directed thrombolysis for the prevention of postthrombotic syndrome in patients with proximal deep vein thrombosis[J]. Am Heart J, 2013, 165(4):523-530.e3. doi: 10.1016/j.ahj.2013.01.024 pmid: 23537968
[14]	WATSON L, BRODERICK C, ARMON M P. Thrombolysis for acute deep vein thrombosis[J]. Cochrane Database Syst Rev, 2016, 11(11):CD002783.
[15]	ADIVITIYA, KHASA Y P. The evolution of recombinant thrombolytics: current status and future directions[J]. Bioengineered, 2017, 8(4):331-358. doi: 10.1080/21655979.2016.1229718 pmid: 27696935
[16]	XING Z, TANG L, ZHU Z, et al. Effects of thrombolysis on outcomes of patients with deep venous thrombosis: an updated meta-analysis[J]. PLoS One, 2018, 13(9):e0204594.
[17]	STEVENS S M, WOLLER S C, KREUZIGER L B, et al. Antithrombotic therapy for VTE disease: second update of the CHEST guideline and expert panel report[J]. Chest, 2021, 160(6):e545-e608.
[18]	DALIBOR M. 10th edition of the ACCP guidelines for dia-gnosis and treatment of venous thromboembolism[J]. Interni Medicina pro Praxi, 2017, 19(1):7-9.
[19]	CHAN S M, LAAGE GAUPP F M, MOJIBIAN H. ClotTriever system for mechanical thrombectomy of deep vein thrombosis[J]. Future Cardiol, 2023, 19(1):29-38.
[20]	NYAMEKYE I K. European Society for Vascular Surgery (ESVS) 2022 clinical practice guidelines on the management of chronic venous disease of the lower limbs[J]. J Med Vasc, 2022, 47(2):53-55. doi: 10.1016/j.jdmv.2022.04.003 pmid: 35691663
[21]	叶炜, 宋小军, 刘志丽, 等. 急性下肢深静脉血栓的血栓清除治疗—CDT还是PMT[J]. 血管与腔内血管外科杂志, 2017, 3(1):559-562.
	YE W, SONG X J, LIU Z L, et al. Thrombosis clearance therapy for acute lower limb venous thrombosis—CDT or PMT[J]. J Vasc Endovasc Surg, 2017, 3(1):559-562.
[22]	宋进华, 何旭, 楼文胜, 等. 急性髂股静脉血栓治疗中AngioJet机械性血栓清除装置初步应用结果[J]. 中华放射学杂志, 2015, 49(10):758-762.
	SONG J H, HE X, LOU W S, et al. Preliminary results of application of percutaneous AngioJet thrombectomy in patients with acute iliofemoral deep venous thrombosis[J]. Chin J Radiol, 2015, 49(10):758-762.
[23]	VEDANTHAM S, GOLDHABER S Z, JULIAN J A, et al. Pharmacomechanical catheter-directed thrombolysis for deep-vein thrombosis[J]. N Engl J Med, 2017, 377(23):2240-2252.
[24]	CONG L, HUANG L, FAN B, et al. Analysis of the efficacy of angiojet percutaneous mechanical thrombectomy combined with catheter-directed thrombolysis versus catheter-directed thrombolysis alone in the treatment of subacute iliofemoral deep venous thrombosis in elderly patients[J]. Phlebology,2024:2683555241273064.
[25]	张茅平, 骆曦图, 黄宝骏, 等. AngioJet机械吸栓联合导管接触性溶栓用于不同病程下肢深静脉血栓形成近期疗效的比较研究[J]. 中华血管外科杂志, 2018, 3(4):222-227.
	ZHANG M P, LUO X T, HUANG B J, et al. Comparison of the short-term clinical effect of AngioJet rheolytic thrombectomy combined with catheter-directed thrombolysis on different courses of deep venous thrombosis[J]. Chin J Vasc Surg, 2018, 3(4):222-227.
[26]	李金旺, 薛军, 郭飞, 等. 系统性溶栓,导管接触性溶栓及AngioJet经皮机械血栓清除术治疗急性下肢深静脉血栓形成疗效的临床对比分析[J]. 中国医学科学院学报, 2023, 45(3):410-415. doi: 10.3881/j.issn.1000-503X.14978
	LI J W, XUE J, GUO F, et al. Clinical comparison of the efficacy of systemic thrombolysis,catheter-directed thrombolysis,and angiojet percutaneous mechanical thrombectomy in acute lower extremity deep venous thrombosis[J]. Acta Acad Med Sin, 2023, 45(3):410-415. doi: 10.3881/j.issn.1000-503X.14978
[27]	SHENG C, LU X W, SHI H T, et al. One-year outcomes of a novel venous stent for symptomatic iliofemoral venous obstruction: prospective cohort study[J]. BMC Med, 2024, 22(1):324. doi: 10.1186/s12916-024-03545-2 pmid: 39113028
[28]	OZCINAR E, DIKMEN N, KAYAN A, et al. Pharmacomechanical thrombectomy and catheter-directed thrombolysis, with or without iliac vein stenting, in the treatment of acute iliofemoral deep vein thrombosis[J]. J Cardiovasc Dev Dis, 2024, 11(7):214.
[29]	赵辉, 胡红耀, 饶珉, 等. 经皮机械性血栓清除术治疗急性髂股静脉血栓[J]. 中国介入影像与治疗学, 2020, 17(7):393-397.
	ZHAO H, HU H Y, RAO M, et al. Percutaneous mechanical thrombectomy for treatment of acute iliofemoral vein thrombi[J]. Chin J Interv Imaging Ther, 2020, 17(7):393-397.
[30]	BIKDELI B, CHATTERJEE S, DESAI N R, et al. Inferior vena cava filters to prevent pulmonary embolism: systematic review and meta-analysis[J]. J Am Coll Cardiol, 2017, 70(13):1587-1597.
[31]	RAY C E JR, PROCHAZKA A. The need for anticoagulation following inferior vena cava filter placement: systematic review[J]. Cardiovasc Intervent Radiol, 2008, 31(2):316-324. doi: 10.1007/s00270-007-9244-x pmid: 18080710
[32]	KAUFMAN J A, BARNES G D, CHAER R A, et al. Socie-ty of interventional radiology clinical practice guideline for inferior vena cava filters in the treatment of patients with venous thromboembolic disease: developed in collaboration with the American college of cardiology, American college of chest physicians, American college of surgeons committee on trauma, American heart association, society for vascular surgery, and society for vascular medicine[J]. J Vasc Interv Radiol, 2020, 31(10):1529-1544.
[33]	翟国钧, 赵军, 韩金涛. 经股静脉切开行下肢深静脉取栓术的安全性与易行性[J]. 中国微创外科杂志, 2008, 8(9):834-836.
	ZHAI G J, ZHAO J, HAN J T. Safety and feasibility of femoral vein thrombectomy for deep vein thrombosis in the lower limbs[J]. Chin J Minim Invasive Surg, 2008, 8(9):834-836.
[34]	MALETI O, ORSO M, LUGLI M, et al. Systematic review and meta-analysis of deep venous reflux correction in chronic venous insufficiency[J]. J Vasc Surg Venous Lymphat Disord, 2023, 11(6):1265-1275.e5. doi: 10.1016/j.jvsv.2023.07.003 pmid: 37453548
[35]	王文斌, 詹焱青, 韩珑, 等. 导管接触性溶栓联合髂静脉支架治疗下肢深静脉血栓形成的疗效及预后分析[J]. 中华全科医学, 2021, 19(9):1439-1441,1446.
	WANG W B, ZHAN Y Q, HAN L, et al. Efficacy and prognosis of catheter-directed thrombolysis combined with iliac vein stenting for deep vein thrombosis[J]. Chin J Gen Pract, 2021, 19(9):1439-1441,1446.
[36]	Matthew S, Jose A. Chapter 17 - deep vein thrombosis and prevention of postthrombotic syndrome[J]. Venous Ulcers, 2023,297-314.
[37]	SICILIANO F, RONCONI E, ROSSI T, et al. Endovascular treatment of lower limb acute DVT: current trends and future directions[J]. CVIR Endovasc, 2024, 7(1):82.
[38]	NOTTEN P, DE SMET A A E A, TICK L W, et al. CAVA (ultrasound-accelerated catheter-directed thrombolysis on preventing post-thrombotic syndrome) trial: long-term follow-up results[J]. J Am Heart Assoc, 2021, 10(11):e018973.
[39]	COMEROTA A J. Pharmacologic and pharmacomechanical thrombolysis for acute deep vein thrombosis: focus on ATTRACT CME[J]. Methodist Debakey Cardiovasc J, 2018, 4(3):219-227.
[40]	ZUIN M, LANG I, CHOPARD R, et al. Innovation in catheter-directed therapy for intermediate-high-risk and high-risk pulmonary embolism[J]. JACC Cardiovasc Interv, 2024, 17(19):2259-2273.
[41]	JIANG L, ZHUANG H, SONG T, et al. Clinical Outcomes at 3 years after stenting for thrombotic and non-thrombotic iliac vein compression syndrome patients[J]. Clin Appl Thromb Hemost, 2024,30:10760296231220053.
[42]	PIETRASIK A, GĄSECKA A, SZARPAK Ł, et al. Cathe-ter-based therapies decrease mortality in patients with intermediate and high-risk pulmonary embolism: evidence from meta-analysis of 65,589 patients[J]. Front Cardiovasc Med, 2022,9:861307.
[43]	MAHNKEN A H, THOMSON K, DE HAAN M, et al. CIRSE standards of practice guidelines on iliocaval stenting[J]. Cardiovasc Intervent Radiol, 2014, 37(4):889-897. doi: 10.1007/s00270-014-0875-4 pmid: 24633533
[44]	QIU P, ZHA B, XU A, et al. Systematic review and meta-analysis of iliofemoral stenting for post-thrombotic syndrome[J]. Eur J Vasc Endovasc Surg, 2019, 57(3):407-416.
[45]	袁涛, 张金文, 张峰, 等. 介入治疗髂静脉受压综合征继发下肢深静脉血栓形成[J]. 河北医科大学学报, 2017, 38(9):1045-1048,1053.
	YUAN T, ZHANG J W, ZHANG F, et al. Interventional treatment of deep venous thrombosis secondary to iliac vein compression syndrome[J]. J Hebei Med Univ, 2017, 38(9):1045-1048,1053.
[46]	尹心怡, 李观强, 张喜成. 髂静脉病变支架植入术后支架内再狭窄的研究进展[J]. 山东大学学报(医学版), 2024, 62(11):8-13,39.
	YIN X Y, LI G Q, ZHANG X C. Research advances in mechanism and treatment of in-stent restenosis after iliac vein stenting[J]. J Shandong Univ (Health Sci), 2024, 62(11):8-13,39.
[47]	ABDUL-HAQQ R, NOVAK Z, PEARCE B J, et al. Routine extended follow-up surveillance of iliac vein stents for iliocaval venous obstruction may not be warranted[J]. J Vasc Surg Venous Lymphat Disord, 2017, 5(4):500-505.
[48]	SAYED M H, SALEM M, DESAI K R, et al. A review of the incidence, outcome, and management of venous stent migration[J]. J Vasc Surg Venous Lymphat Disord, 2022, 10(2):482-490. doi: 10.1016/j.jvsv.2021.07.015 pmid: 35026448
[49]	GUO B, CHEN C, LI Y, et al. Principles of optimal antithrombotic therapy for Iliac venous stenting (POATIVES): a national expert-based Delphi consensus study[J]. J Vasc Surg Venous Lymphat Disord, 2024, 12(2):101739.
[50]	钟文, 楼燕, 邱宸阳, 等. 髂静脉支架植入术后药物治疗策略研究进展[J]. 浙江大学学报(医学版), 2020, 49(1):131-136.
	ZHONG W, LOU Y, QIU C Y, et al. Antithrombotic therapy after iliac vein stenting[J]. J Zhejiang Univ(Med Sci), 2020, 49(1):131-136.